Cytomegalovirus Infections: all 362 studies
Page 1 of 4. Open to participants first (59), then studies with results posted, then the rest; newest registration first within each.
- CMV Refractory and Resistant Infection in Solid Organ Transplant Recipients in ArgentinaNot yet recruitingNCT07787767
- CMV-CMI in csCMVi After HSCTRecruitingNCT07688759
- Evaluation of Safety and Efficacy of Virus Specific T-Cell Administration in Pediatric Patients With Systemic Viral Infection Following Allogeneic Hematopoietic Stem Cell Transplantation.RecruitingNCT07685457Not applicable
- Evaluation of the Safety and Efficacy of LB-DTK-MV in Patients Diagnosed With Antiviral-Resistant CMV, BKV, or EBV Infection or Associated Diseases Following Anticancer Therapy or Allogeneic Hematopoietic Stem Cell Transplantation.RecruitingNCT07670468Phase 1/2
- Protein Biomarkers and Host RNA Expression Profiles in Congenital Cytomegalovirus InfectionRecruitingNCT07635368
- Letermovir vs Valganciclovir in CMV R+ Kidney TransplantNot yet recruitingNCT07571135Phase 4
- HORUS-Cytomegalovirus Open Proof-of-concept Exploratory TrialNot yet recruitingNCT07570433Phase 4
- Letermovir Prophylaxis Duration Guided by CMV-Specific T-cell Monitoring After Allo-HSCT.RecruitingNCT07569653Phase 4
- Systemic and Topical Antiviral Control of Cytomegalovirus Anterior Uveitis: Treatment Outcomes - Trials I and IINot yet recruitingNCT07513623Phase 2
- Renal Ex Vivo SYN002 Perfusion to Eliminate CMV TransmissionNot yet recruitingNCT07488481Early Phase 1
- Evaluation of Long-term Efficacy of 4 to 6-month Course Antiviral Therapy for Neurodevelopmental Impairments Caused by Congenital Cytomegalovirus InfectionNot yet recruitingNCT07450365Phase 4
- Reducing Post-Letermovir CMV Infection: Efficacy of an Immune-Reconstitution-Based Scoring System to Guide Prophylaxis DurationNot yet recruitingNCT07443501
- ValgaNciclovIR for CMV Viraemia in AdvaNced HIV diseAseNot yet recruitingNCT07379203Phase 2
- Overview of Targeted Screening for Congenital Infection Guided by Neonatal Hearing ScreeningRecruitingNCT07335874
- Is Valacyclovir Non-inferior to Valganciclovir as CMV and EBV Prophylaxis in Kidney Transplant Recipients? A Single-Center Prospective Randomized Pilot StudyRecruitingNCT07294547Not applicable
- Phase 3 Randomized Trial for Refractory ADV or CMV Infection With Family Matched CTLs and Standard of Care (SOC) vs SOC AloneRecruitingNCT07225972Phase 3
- HCMV-miRNA Monitoring After Allogeneic Hematopoietic Stem Cell Transplantation Using PSTM-qPCRNot yet recruitingNCT07210242
- A Prospective Single-Arm Observational Study of Maribavir for the Treatment of Post Hematopoietic Stem Cell Transplantation Cytomegalovirus InfectionNot yet recruitingNCT07141095
- TETRAVI Expanded Access ProgramAvailableNCT07104591
- Immunoglobiulin-specific Prophylaxis of Citomegalovirus Infections in Immunocompromised Children Undergoing Allogeneic Hematopoietic Stem Cell TransplantationRecruitingNCT07013370
- CytoGam for CMV Infection or Disease in Solid Organ Transplant RecipientsEnrolling by invitationNCT07009548Phase 4
- CMV-associated Immunomodulation in Renal Transplant PatientsNot yet recruitingNCT06976008Not applicable
- R-MVST Cells for Treatment of Viral Infections in Children and Young AdultsRecruitingNCT06926894Phase 1
- Burden of Cytomegalovirus Reactivation in Pediatric Patients After Allogeneic Hematopoietic Stem Cell TransplantationRecruitingNCT06916195
- Viral Specific T-Lymphocytes to Treat Infection With Adenovirus, Cytomegalovirus or Epstein-Barr Virus in Patients With Compromised ImmunityRecruitingNCT06909110Phase 1/2
- Study Evaluating the Efficacy and Safety of ArtesunateRecruitingNCT06853184Phase 2
- Efficacy of Extended Letermovir Prophylaxis to Prevent CMV Reactivation in High-Risk Chinese Adults Undergoing Allogeneic HSCTRecruitingNCT06812598Not applicable
- Evaluation of Software for Interpreting Virological Results Indicated for the Diagnosis of Cytomegalovirus (CMV) Infection During Pregnancy and Intended for Health ProfessionalsRecruitingNCT06694428
- ATG Individualized Dosing Model in URD-PBSCT.RecruitingNCT06572462Phase 2
- Effect of Letermovir Prophylaxis on CMV-specific Immune Reconstitution Post UCBTRecruitingNCT06441669
- Letermovir (Prevymis) for CMV in Kidney and Pancreas Transplant RecipientsRecruitingNCT06407232Phase 3
- The Comparison the CMV Infection and Reactivation After Allogeneic Hematopoietic Stem Cell Transplantation Between Standard Regimen, Methotrexate Plus Cyclosporin A, and Post-transplant Cyclophosphamide-based RegimenNot yet recruitingNCT06362720
- Evaluation of the Prophylactic Use of Letermovir in Kidney Transplant Recipients at Risk of Cytomegalovirus InfectionNot yet recruitingNCT06341686Phase 3
- Quantiferon CMV to Identify Treatment Need for Asymptomatic CMV Infection After Solid Organ Transplant (QUANTIFOT)RecruitingNCT06341543Not applicable
- HCMV Breakthrough Infections During Letermovir ProphylaxisRecruitingNCT06339892Not applicable
- Letermovir-based Dual Therapy for Treatment of Cytomegalovirus InfectionsRecruitingNCT06334497Phase 3
- Observational Clinical Study of Letermovir for Preventing CMV Infection After Allo-HSCTRecruitingNCT06306989
- Real-world CMV Outcomes Among Kidney Transplant Recipients in BrazilEnrolling by invitationNCT06263218
- Long-Term Outcomes of Children With Congenital CMV in New York StateRecruitingNCT06226558
- Multivirus-specific T Cells in the Treatment of Refractory CMV and/or EBV Infection After Allo-HSCTNot yet recruitingNCT06075927Phase 1/2
- Incidence and Risks Factors of CMV Reactivation in Patients Receiving of CAR-T Cells for Acute Leukemia and Lymphoma Relapse, a Cohort Study AnalysisRecruitingNCT06058858
- Efficacy of Letermovir in Preventing Cytomegalovirus (CMV) Infection in Lung Transplant Recipients vs. Valganciclovir.Not yet recruitingNCT06057194Phase 2
- Anti-viral T-cell Therapy by Gamma CaptureEnrolling by invitationNCT06027879Phase 1/2
- Letermovir for the Prevention of CMV Infection in HSCT Recipients Based on the Outcome of mNGSRecruitingNCT06021210Phase 2
- Letermovir for Primary Prophylaxis of Cytomegalovirus Infection After R+HID-HSCTNot yet recruitingNCT05914675Phase 4
- Observational Study of the Management of Infants With Congenital CMVRecruitingNCT05855889
- Immune Reconstitution to CMV After HSCT: Impact of Clinical Factors and Therapy StrategiesEnrolling by invitationNCT05656599
- Letermovir for Secondary Prophylaxis in Solid Organ Transplant RecipientsRecruitingNCT05626530Phase 4
- Ganciclovir Resistant/Refractory Cytomegalovirus Infection in SOT Recipients and HSCT PatientsRecruitingNCT05234723
- R-MVST Cells for Treatment of Viral InfectionsRecruitingNCT05183490Phase 1
- Multivirus-specific T-cell Transfer Post SCT vs AdV, CMV and EBV InfectionsRecruitingNCT04832607Phase 3
- Congenital CYtoMEgalovirus Infection in VIEtnam (CYMEVIE)RecruitingNCT04822142
- Breakthrough CMV Lung Transplant -MulticentreRecruitingNCT04439916
- QuantiFERON-CMV Test in a Prediction for Colic Cytomegalovirus Reactivation During Ulcerative ColitisRecruitingNCT04030676Not applicable
- Cytomegalovirus (CMV) Reactivation in Allogeneic HSCT RecipientEnrolling by invitationNCT03806764Not applicable
- Multi-antigen CMV-Modified Vaccinia Ankara Vaccine in Treating Pediatric Patients With Positive Cytomegalovirus Undergoing Donor Stem Cell TransplantRecruitingNCT03354728Phase 1/2
- Virus Specific Cytotoxic T-Lymphocytes (CTLs) for Refractory Cytomegalovirus (CMV)RecruitingNCT03266640Phase 2
- T Cell Therapy of Opportunistic Cytomegalovirus InfectionRecruitingNCT02982902Early Phase 1
- A Study to Assess Safety and Feasibility of Direct Infusions of Donor-derived Virus-specific T-cells in Recipients of Hematopoietic Stem Cell Transplantation With Post-transplant Viral Infections Using the Cytokine Capture System®RecruitingNCT02007356Phase 2
- A Study of Letermovir (MK-8228) to Evaluate Efficacy and Safety for Prevention of Cytomegalovirus Infection in Chinese Hematopoietic Stem Cell Transplant Recipients (MK-8228-045)CompletedNCT05763823Phase 3Results posted
- Study of Posoleucel (ALVR105,Viralym-M) for Multi-Virus Prevention in Patients Post-Allogeneic Hematopoietic Cell TransplantTerminatedNCT05305040Phase 2/3Results posted
- A Study of Maribavir in Japanese People With Cytomegalovirus (CMV) InfectionCompletedNCT05137717Phase 3Results posted
- Trial to Evaluate the Safety and Immunogenicity of a Modified Vaccinia Ankara (MVA)-Based Anti-Cytomegalovirus (CMV) Vaccine (Triplex®)CompletedNCT05099965Phase 2Results posted
- A Study of Safety and Immune Response to Different Doses of a Cytomegalovirus Vaccine in Healthy AdultsCompletedNCT05089630Phase 1/2Results posted
- Letermovir Use in Heart Transplant RecipientsCompletedNCT04904614Phase 4Results posted
- A Study to Evaluate the Anti-inflammatory Effects of Letermovir (Prevymis) in Adults With Human Immunodeficiency Virus (HIV)-1 and Asymptomatic Cytomegalovirus (CMV) Who Are on Suppressive Antiretroviral Therapy, Plus Its Effect on Chronic Inflammation, HIV Persistence and Other Clinical Outcomes.TerminatedNCT04840199Phase 2Results posted
- Posoleucel (ALVR105, Formerly Viralym-M) for Multi-Virus Prevention in Patients Post-Allogeneic Hematopoietic Cell TransplantCompletedNCT04693637Phase 2/3Results posted
- Viral Specific T-Lymphocytes to Treat Adenovirus, CMV and EBVTerminatedNCT04364178Phase 1/2Results posted
- Dose-Finding Trial to Evaluate the Safety and Immunogenicity of Cytomegalovirus (CMV) Vaccine mRNA-1647 in Healthy AdultsCompletedNCT04232280Phase 2Results posted
- A Study for Kidney Transplant Recipients at High-Risk of Cytomegalovirus InfectionCompletedNCT04225923Phase 2Results posted
- MK-8228 (Letermovir) in the Prevention of Human Cytomegalovirus (CMV) Infection and Disease in Adult Japanese Kidney Transplant Recipients (MK-8228-042)CompletedNCT04129398Phase 3Results posted
- A Study of the Drug Letermovir (LTV) as Prevention for Recurrent of Cytomegalovirus (CMV) InfectionCompletedNCT04017962Phase 2Results posted
- Letermovir Treatment in Pediatric Participants Following Allogeneic Haematopoietic Stem Cell Transplantation (HSCT) (MK-8228-030)CompletedNCT03940586Phase 2Results posted
- Extension of Letermovir (LET) From Day 100 to Day 200 Post-transplant for the Prevention of Cytomegalovirus (CMV) Infection in Hematopoietic Stem Cell Transplant (HSCT) Participants (MK-8228-040)CompletedNCT03930615Phase 3Results posted
- Dried Blood Spot Testing of CMV Detection in HCT RecipientsCompletedNCT03910478Not applicableResults posted
- Safety and Immunogenicity of the Human Cytomegalovirus (CMV) Vaccine (V160) in Healthy Japanese Men (V160-003)CompletedNCT03840174Phase 1Results posted
- Letermovir Treatment for Refractory or Resistant Cytomegalovirus InfectionCompletedNCT03728426Phase 2Results posted
- A Study of CMV Vaccine (HB-101) in Kidney Transplant PatientsCompletedNCT03629080Phase 2Results posted
- V160 2-Dose and 3-Dose Regimens in Healthy Cytomegalovirus (CMV) Seronegative Females (V160-002)CompletedNCT03486834Phase 2Results posted
- Cytomegalovirus (CMV) Vaccines: Reinfection and Antigenic VariationCompletedNCT03443791Not applicableResults posted
- Asymptomatic Congenital CMV TreatmentTerminatedNCT03301415Phase 2Results posted
- Randomized Controlled Trial of Valganciclovir for Cytomegalovirus Infected Hearing Impaired InfantsTerminatedNCT03107871Phase 2Results posted
- Efficacy and Safety Study of Maribavir Treatment Compared to Investigator-assigned Treatment in Transplant Recipients With Cytomegalovirus (CMV) Infections That Are Refractory or Resistant to Treatment With Ganciclovir, Valganciclovir, Foscarnet, or CidofovirCompletedNCT02931539Phase 3Results posted
- A Study of Maribavir Compared to Valganciclovir to Treat Cytomegalovirus Infections in People Who Have Received Stem Cell TransplantsCompletedNCT02927067Phase 3Results posted
- Study to Evaluate Safety, Tolerability, and Immunogenicity of Candidate Human Cytomegalovirus Vaccine in Healthy AdultsCompletedNCT02826798Phase 1Results posted
- Study of SHP620 (Maribavir) in Healthy AdultsCompletedNCT02775240Phase 1Results posted
- Multi-antigen CMV-MVA Triplex Vaccine in Reducing CMV Complications in Patients Previously Infected With CMV and Undergoing Donor Hematopoietic Cell TransplantActive, not recruitingNCT02506933Phase 2Results posted
- A Phase 3 Study of Brincidofovir Versus Valganciclovir for the Prevention of Cytomegalovirus DiseaseTerminatedNCT02439970Phase 3Results posted
- A Phase 3 Study of Brincidofovir Versus Valganciclovir for the Prevention of CytomegalovirusTerminatedNCT02439957Phase 3Results posted
- Vaccine Therapy in Reducing the Frequency of Cytomegalovirus Events in Patients With Hematologic Malignancies Undergoing Donor Stem Cell TransplantCompletedNCT02396134Phase 2Results posted
- Autologous Cytomegalovirus (CMV)-Specific Cytotoxic T Cells for Cytomegalovirus (CMV) ReactivationCompletedNCT02210065Phase 2Results posted
- Letermovir (MK-8228) Versus Placebo in the Prevention of Clinically-Significant Cytomegalovirus (CMV) Infection in Adult, CMV-Seropositive Allogeneic Hematopoietic Stem Cell Transplant Recipients (MK-8228-001)CompletedNCT02137772Phase 3Results posted
- Trial of Third Party Donor Derived CMVpp65 Specific T-cells for The Treatment of CMV Infection or Persistent CMV Viremia After Allogeneic Hematopoietic Stem Cell TransplantationCompletedNCT02136797Phase 2Results posted
- The Influence of Chronic CMV Infection on Influenza Vaccine ResponsesCompletedNCT02134184Phase 4Results posted
- An Observational Study of Valcyte (Valganciclovir) in D+/R- Liver Transplant RecipientsCompletedNCT02062294Results posted
- Safety, Tolerability, and Immunogenicity of the Human Cytomegalovirus Vaccine (V160) in Healthy Adults (V160-001)CompletedNCT01986010Phase 1Results posted
- A Study to Evaluate the Efficacy and Safety of a Vaccine, ASP0113, in Cytomegalovirus (CMV)-Seronegative Kidney Transplant Recipients Receiving an Organ From a CMV-Seropositive DonorCompletedNCT01974206Phase 2Results posted
- ValGanciclovir Versus ValAcyclovir for Viral Prophylaxis in Kidney TransplantationCompletedNCT01972035Phase 2Results posted
- A Study to Evaluate a Therapeutic Vaccine, ASP0113, in Cytomegalovirus (CMV)-Seropositive Recipients Undergoing Allogeneic, Hematopoietic Cell Transplant (HCT)CompletedNCT01877655Phase 3Results posted
- A Study in Adolescent Females to Explore Cytomegalovirus InfectionCompletedNCT01691820Not applicableResults posted